Product Information
TERBUTALINE SULFATE 5 MG TAB is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.5862 per EA under NDC 24979013301. Its NADAC has been published 135 times since Apr 17, 2024.
FDA first approved this application on Jun 19, 2020.
Strength
5 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
24979013301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
10/21/2026
Active Ingredients
TERBUTALINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA211832FDA Approved
6/19/2020
On Market Since
7/13/2020
Price Statistics
The NADAC for TERBUTALINE SULFATE 5 MG TAB has been published 135 times since Apr 17, 2024, and over the history we have for it it has declined 63.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5862 per EA |
|---|---|
| All-time high | $1.8211 (Jun 12, 2024) |
| All-time low | $0.5862 (Oct 21, 2026) |
| 52-week high | $1.3632 |
| 52-week low | $0.5862 |
| Median price | $1.2800 |
| Average price | $1.2860 |
| Largest weekly change | -26.4% (Jul 22, 2026) |
| Weeks tracked | 135 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Terbutaline Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TERBUTALINE SULFATE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TERBUTALINE SULFATE 5 MG TAB, manufactured by Upsher-Smith Laboratories LLC, is $0.5862 per EA (NDC 24979013301), effective Nov 11, 2026.
How has the price of TERBUTALINE SULFATE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for TERBUTALINE SULFATE 5 MG TAB has declined 63.7%. It has been tracked across 135 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TERBUTALINE SULFATE 5 MG TAB?
Since Apr 17, 2024, the NADAC for TERBUTALINE SULFATE 5 MG TAB has ranged from a low of $0.5862 (Oct 21, 2026) to a high of $1.8211 (Jun 12, 2024), with a median of $1.2800 per EA.
Are there cheaper alternatives to TERBUTALINE SULFATE 5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERBUTALINE SULFATE 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures TERBUTALINE SULFATE 5 MG TAB?
TERBUTALINE SULFATE 5 MG TAB (NDC 24979013301) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.